您所在的位置: 首页 --> 导师团队 --> 苏向前

导师基本信息

  • 姓名:苏向前
  • 科室:胃肠肿瘤中心四病区
  • 职称:主任医师
  • 专业:肿瘤学
  • E-MAIL: suxiangqian@gmail.com

研究方向

胃肠肿瘤的临床与基础研究

胃肠肿瘤精准医学研究

胃肠肿瘤转化医学研究

发表学术论文| 出版的专著| 获得的成果、奖励

Liu M, Liu Y, Di J, Su Z, Yang H, Jiang B, Wang Z, Zhuang M, Bai F*, Su X(苏向前)*. Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer.

Di J, Zhuang M, Yang H, Jiang B, Wang Z, Su X(苏向前)*. Clinical significance of circulating immune cells in left- and right-sided colon cancer.

Di J, Yang H, Jiang B, Wang Z, Ji J, Su X(苏向前)*. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.

Mingshan Liu, Jiabo Di, Yang Liu, Zhe Su, Beihai Jiang, Zaozao Wang, Xiangqian Su(苏向前)*. Comparison of EpCAM high CD44+ cancer stem cells with EpCAM high CD44- tumor cells in colon cancer by single-cell sequencing.

Wu W, Wu F, Wang Z, Di J, Yang J, Gao P, Jiang B*, Su X(苏向前)*. CENPH inhibits rapamycin sensitivity by regulating GOLPH3-dependent mTOR signaling pathway in colorectal cancer.

Zhuang M, Peng Z, Wang J, Su X(苏向前)*. Vascular endothelial growth factor gene polymorphisms and gastric cancer risk: a meta-analysis.

Wang Z, Yang J, Di J, Cui M, Xing J, Wu F, Wu W, Yang H, Zhang C, Yao Z, Zhang N, Jiang B*, Su X(苏向前)*. Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer.

Cui M, Xing JD, Yang W, Ma YY, Yao ZD, Zhang N, Su XQ*. Comparison of D2 dissection in laparoscopic and open gastrectomy for gastric cancer.

Chen L, Jiang B, Wang Z, Liu M, Ma Y, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Cui M, Su X*. Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer.

Chen D, Jiang B, Xing J, Liu M, Cui M, Liu Y, Wang Z, Chen L, Yang H, Zhang C, Yao Z, Zhang N, Ji J, Qu H*, Su X*. Validation of the Memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population

Wang Z, Jiang B, Chen L, Di J, Cui M, Liu M, Ma Y, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Dong B, Ji J, Su X*. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.

Chen L, Jiang B, Wang Z, Liu M, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Cui M, Su X*. Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.

Liu M#, Qu H#, Bu Z#, Chen D, Jiang B, Cui M, Xing J, Yang H, Wang Z, Di J, Chen L, Zhang C, Yao Z, Zhang N, Tan F, Gu J, Li Z, Su X*

Liu X, Jiang B, Wang A, Di J, Wang Z, Chen L, Su X(苏向前)*. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.

Cui M, Li Z, Xing J, Yao Z, Liu M, Chen L, Zhang C, Yang H, Zhang N, Tan F, Jiang B, Di J, Wang Z, Ji J, Su X(苏向前)*. A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer.

Cui M, Gong C, Jiang B, Yao Z, Chen L, Di J, Xing J, Yang H, Zhang C, Zhang N, Liu M, Tan F, Wang Z, Su X(苏向前)*. Evaluation of immune responses of gastric cancer patients treated by laparoscopic and open gastrectomy.

Zhang C, Di J, Jiang B, Cui M, Wang Z, Xing J, Yang H, Yao Z, Zhang N, Su X(苏向前)*. Prognostic factors for patients with stage II colon cancer: results of a prospective study.

Hu Y#, Huang C#, Sun Y#, Su X(苏向前)#, Cao H, Hu J, Xue Y, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Chen P, Liu H, Zheng C, Liu F, Yu J, Li Z, Zhao G, Chen X, Wang K, Li P, Xing J, Li G.

Xu K, Wang J, Gao J, Di J, Jiang B, Chen L, Wang Z, Wang A, Wu F, Wu W, Shen L, Su X(苏向前)*. GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.

Wang A, Cui M, Qu H, Di J, Wang Z, Xing J, Wu F, Wu W, Wang X, Shen L, Jiang B*, Su X(苏向前)*. Induction of anti-EGFR immune response with mimotopes identified from a phage display peptide library by panitumumab.

<SPAN style="FONT-SIZE: 14pt; FONT-FAMILY: 宋体; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'"><FONT size=2>苏向前*, 邢加迪. 直肠癌Miles术后会阴部复发的诊断与多学科综合治疗.</FONT> </SPAN>

社会任职

  • 内蒙古科学技术奖励评审委员
  • 科技部“创新人才推进计划”评议专家
  • 中国医师协会外科医师分会结直肠外科医师委员会副主任委员
  • 中国抗癌协会大肠癌专业委员会腹腔镜学组委员
  • 中国抗癌协会胃癌专业委员会委员
  • 中国抗癌协会大肠癌专业委员会委员
  • 北京市卫生系列高级专业技术职务任职资格评审专家库专家
  • 北京市自然科学基金评审专家库专家
  • 国家科技奖励评审专家库专家
  • 国家自然科学基金评审专家库专家
  • 中华结直肠疾病电子杂志编委
  • 中华胃肠外科杂志编委
  • 北京市海淀区医疗事故鉴定专家库专家
  • 《消化肿瘤杂志(电子版)》编委
  • 《中华腔镜外科杂志(电子版)》编委
  • 《中国实用外科杂志》编委
  • 中华医学会北京肠内外营养专业委员会委员
  • 中华医学会北京外科专业委员会委员
  • 中华医学会外科分会外科手术学组委员
  • 中国医师协会外科医师分会微创外科医师专业委员会委员
  • 亚洲内镜与腹腔镜外科医师协会会员(ELSA)
  • 欧洲内视镜外科协会会员(EATS)
  • 美国胃肠与内镜外科医师协会会员(SAGES)

学习、工作经历

  • 2011.7~至今,北京大学肿瘤医院副院长,北京肿瘤医院副院长,北京市肿瘤防治研究所副所长,胃肠肿瘤微创外科主任,主任医师
  • 2001.4~2014.2,北京大学肿瘤医院,胃肠外科 副教授
  • 2009.4~2011.6,北京肿瘤医院(北京市肿瘤防治研究所),胃肠肿瘤微创外科主任,主任医师
  • 2008.4~2009.4,北京大学肿瘤医院,胃肠外科 主任医师
  • 2007.1~2008.4,美国UCLA(University of California, Los Angeles Surgical Oncology and Minimal Invasive Surgery),访问学者
  • 1999.9~2008.4,北京大学肿瘤医院,胃肠外科 副主任医师
  • 1996.9~1999.7,北京肿瘤医院(北京市肿瘤防治研究所),硕士研究生
  • 1984.8~1996.9,内蒙古包头市肿瘤医院,外科,住院医师、主治医师
  • 1979.9~1984.8,内蒙古医学院,临床医学,本科